SEC Company Response from ABBOTT LABORATORIES (ABT) — Apr 8, 2011
ABBOTT LABORATORIES
Date: April 8, 2011 · CIK: 0000001800 · Accession: 0001104659-11-019301
AI Filing Summary & Sentiment
File numbers found in text: 001-02189
Referenced dates: March 31, 2011
Letter
United States Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Abbott Laboratories Comment Letter dated March 31, 2011 File Number 001-02189
RE:
Dear Ms. Nakada:
Abbott will not be able to respond to the comment letter from the staff of the Securities and Exchange Commission dated March 31, 2011 by April 14, 2011, the date requested by the staff, given that we are also in the process of closing our books and preparing our financial results for the first quarter of 2011 during this period. We will move the process to respond to the comment letter along expeditiously, and expect to provide a response by April 28, 2011.
If you have any questions, please feel free to contact me at 847-937-5952.
Very truly yours,
Greg W. Linder
Show Raw Text
CORRESP 1 filename1.htm April 8, 2011 Ms. Keira Nakada United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4720 100 F Street NE Washington, D.C. 20549 RE: Abbott Laboratories Comment Letter dated March 31, 2011 File Number 001-02189 Dear Ms. Nakada: Abbott will not be able to respond to the comment letter from the staff of the Securities and Exchange Commission dated March 31, 2011 by April 14, 2011, the date requested by the staff, given that we are also in the process of closing our books and preparing our financial results for the first quarter of 2011 during this period. We will move the process to respond to the comment letter along expeditiously, and expect to provide a response by April 28, 2011. If you have any questions, please feel free to contact me at 847-937-5952. Very truly yours, Greg W. Linder Vice President and Controller